License-Out
License Agreement Has Been Entered into with KarisBio, Inc.
We have executed a non-exclusive therapeutic use license agreement with KarisBio, Inc. (Republic of Korea) for commercial use of the patents on iPS cell technologies licensed to us by Kyoto University.
